Cargando…
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
The transmembrane chemokines CX3CL1/fractalkine and CXCL16 are widely expressed in different types of tumors, often without an appropriate expression of their classical receptors. We observed that receptor-negative cancer cells could be stimulated by the soluble chemokines. Searching for alternative...
Autores principales: | Hattermann, Kirsten, Gebhardt, Henrike, Krossa, Sebastian, Ludwig, Andreas, Lucius, Ralph, Held-Feindt, Janka, Mentlein, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739769/ https://www.ncbi.nlm.nih.gov/pubmed/26796342 http://dx.doi.org/10.7554/eLife.10820 |
Ejemplares similares
-
The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16
por: Adamski, Vivian, et al.
Publicado: (2017) -
“Inverse signaling” of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells
por: Hattermann, Kirsten, et al.
Publicado: (2016) -
Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells
por: Hattermann, Kirsten, et al.
Publicado: (2014) -
Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1
por: Adamski, Vivian, et al.
Publicado: (2020) -
Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7
por: Meincke, Manuela, et al.
Publicado: (2011)